Reply to letters regarding our paper "Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Societyˮ

Indian Pacing Electrophysiol J. 2020 Sep-Oct;20(5):209-210. doi: 10.1016/j.ipej.2020.06.007. Epub 2020 Jul 10.
No abstract available

Keywords: COVID-19; Hydroxychloroquine; QTc interval.

Publication types

  • Letter